Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease-Reference-Cited by-同舟云学术

Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease

Published:2015-04-20 Issue:6 Volume:47 Page:577-578
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Gutierrez-Achury Javier,Zhernakova Alexandra,Pulit Sara L,Trynka Gosia^ORCID,Hunt Karen A,Romanos Jihane,Raychaudhuri Soumya,van Heel David A^ORCID,Wijmenga Cisca,de Bakker Paul I W^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3268.pdf

Reference21 articles.

1. Liu, E. et al. N. Engl. J. Med. 371, 42–49 (2014).

2. Romanos, J. et al. Gastroenterology 137, 834–840 (2009).

3. Trynka, G. et al. Nat. Genet. 43, 1193–1201 (2011).

4. Hunt, K.A. et al. Nature 498, 232–235 (2013).

5. Westra, H.J. et al. Nat. Genet. 45, 1238–1243 (2013).

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the HLA complex in autoimmunity: From the risk haplotypes to the modulation of expression;Clinical Immunology;2024-08

2. Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes;Journal of Biological Chemistry;2024-08

3. Discovery of runs-of-homozygosity diplotype clusters and their associations with diseases in UK Biobank;eLife;2024-06-21

4. New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease;Gastroenterology;2024-06

5. From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?;Frontiers in Pharmacology;2024-04-18